What Melatonin Actually Does
Melatonin is a hormone produced by the pineal gland that signals to the brain that it is night-time. Its primary role is in regulating circadian timing, the internal 24-hour clock that governs when you feel sleepy, when you wake, and when biological systems like core body temperature and cortisol follow their daily patterns. Melatonin does not directly promote deep sleep or maintain sleep continuity. It is a timing cue, not a sedative.
Melatonin production changes with age. Peak melatonin secretion in women typically begins to decline from the mid-40s onward, coinciding with the perimenopausal transition. By postmenopause, melatonin levels are often measurably lower than in younger reproductive-age women. This decline contributes to circadian disruption, difficulty falling asleep at the expected time, waking earlier than desired, and a general flattening of the robust day-night melatonin rhythm that anchors consolidated sleep.
Supplemental melatonin at low doses (0.5–1 mg) taken 30–60 minutes before the desired sleep time can help shift sleep onset earlier and re-entrench circadian timing in women who experience difficulty falling asleep. This use case, circadian phase correction, is where melatonin has the most robust evidence base, and it is a reasonable option for women whose primary complaint is difficulty initiating sleep.
Why Melatonin Alone Is Insufficient for Most Menopausal Sleep Problems
The sleep disruption that characterises perimenopause and menopause is multifactorial and goes well beyond melatonin decline. Simply supplementing melatonin does not address the primary drivers of menopausal sleep disturbance:
Night sweats and hot flashes are among the most potent disruptors of sleep continuity. The neurological cascade that triggers a vasomotor event activates the sympathetic nervous system and raises core body temperature, both of which are incompatible with deep sleep. A hot flash that occurs during non-REM or REM sleep often does not fully wake a woman but fragments her sleep architecture, robbing her of deep and restorative stages. Melatonin does not reduce the frequency or intensity of night sweats.
Cortisol dysregulation is commonly elevated during perimenopause, particularly in the early morning hours. The hyperactivation of the HPA (hypothalamic-pituitary-adrenal) axis in the transition contributes to early morning waking, often at 3–4am, that is very difficult to address with melatonin alone.
Reduced deep sleep is a structural feature of hormonal transition. Progesterone has direct sleep-promoting properties, and as it declines, slow-wave (deep) sleep decreases. This is detectable on sleep architecture studies and contributes to the experience of sleeping the same number of hours but waking unrefreshed. Melatonin does not restore slow-wave sleep.
Anxiety and hyperarousal, common in perimenopause, create a state of pre-sleep mental activation that melatonin cannot overcome. These require different interventions.
Evidence Review: What the Research Shows
Published randomised controlled trials on melatonin supplementation in menopausal women show modest but inconsistent benefits. A 2020 systematic review published in Maturitas found that melatonin supplementation improved subjective sleep quality and sleep onset in peri- and postmenopausal women, with effects on mood and cognitive function also observed. However, the studies were heterogeneous, sample sizes small, and the quality of evidence moderate.
There is also some preliminary evidence that melatonin may have beneficial effects on bone mineral density in postmenopausal women, and potentially on mood, though these are secondary findings rather than primary sleep outcomes.
Practical Guidance
If you decide to try melatonin, lower doses (0.5–1 mg) are generally considered as effective as higher doses (3–10 mg) for circadian timing purposes, and carry fewer next-day grogginess effects. Dose timing matters more than dose size. It should be taken in a dim environment, away from screens, as light exposure at the time of dosing can nullify its effect.
Melatonin is most likely to be helpful if your primary problem is difficulty falling asleep at a reasonable hour, you are affected by shift work or significant travel disruption, or your sleep timing has shifted significantly earlier or later than desired.
It is unlikely to meaningfully help if your predominant issues are night sweats waking you, frequent 3am waking, or chronic non-restorative sleep without a clear sleep onset problem.
For menopausal sleep disruption, the most evidence-supported approaches remain HRT (for women for whom it is appropriate) to address vasomotor triggers, cognitive behavioural therapy for insomnia (CBT-I) for sleep and wake cognition work, and nervous system regulation strategies to address the elevated cortisol and sympathetic activation that drive early waking.
Melatonin can play a supporting role, particularly for circadian anchoring, within a broader sleep management strategy. It should not be the primary or sole intervention for complex menopausal sleep disruption.
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making any changes to your health management.